Biotinylated Human HLA-A*02:01&B2M&p53 (HMTEVVRHC) Complex Protein (Monomer, MALS verified)
TP53 has been recognized as a tumor suppressor. 50% of cancers carry a TP53 mutation while many others affect other pathway components. High-copy numbers of WT p53 peptide-MHC class I complexes were detected on tumor cells as compared to low copies on normal cells. The Human HLA-A*0201 p53 (HMTEVVRHC) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and HMTEVVRHC peptide of the p53.
Product Specifications
Background
Specifications
Accession Number
P61769-1 (B2M) & AAA59606.1 (HLA-A*02:01) & HMTEVVRHC
Expression Region
Ile 21 - Met 119 (B2M) & Gly 25 - Ile 308 (HLA-A*02:01) & HMTEVVRHC peptide
Host
HEK293
Target
HLA-A*0201 & B2M & p53 (HMTEVVRHC)
Conjugation
Biotin-labeled
Tag
C-10xHis & C-Avi
Source
Human
Stability
Endotoxin
1.0 EU per μg
Purity
90%
Bioactivity
Format
Powder
Buffer
PBS, pH7.4
Additives
Trehalose
Molecular Weight
49.3 kDa
Additionnal Information
Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments
Shipping Conditions
RT
Storage Conditions
-20°C
Package Size
25ug*1
Host or Source
HEK293
Species
Human
Protein ID
P61769-1 (B2M) & AAA59606.1 (HLA-A*02:01) & HMTEVVRHC
Preservative
Trehalose
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (VU-1D9), CF405S conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF405S conjugate, 0.1mg/mL
P27 / KIP1 (SX53G8), CF740 conjugate, 0.1mg/mL
CD10 (CB-CALLA), CF405S conjugate, 0.1mg/mL
